Celltrion
068270.KS
#793
Rank
ยฃ18.45 B
Marketcap
ยฃ84.76
Share price
0.00%
Change (1 day)
-15.00%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Market capitalization of Celltrion (068270.KS)

Market cap: ยฃ18.45 Billion

As of April 2025 Celltrion has a market cap of ยฃ18.45 Billion. This makes Celltrion the world's 793th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Celltrion from 2007 to 2025

End of year Market Cap

Year Marketcap Change
2025ยฃ18.45 B-12.25%
2024ยฃ21.02 B-19.98%
2023ยฃ26.27 B75.36%
2022ยฃ14.98 B-12.76%
2021ยฃ17.17 B-48.07%
2020ยฃ33.08 B117.86%
2019ยฃ15.18 B-22.39%
2018ยฃ19.56 B2.73%
2017ยฃ19.04 B116.17%
2016ยฃ8.81 B61.54%
2015ยฃ5.45 B134.46%
2014ยฃ2.32 B7.57%
2013ยฃ2.16 B-19.56%
2012ยฃ2.68 B14.44%
2011ยฃ2.34 B5.2%
2010ยฃ2.23 B174.03%
2009ยฃ0.81 B48.09%
2008ยฃ0.55 B5752.02%
2007ยฃ9.4 M

End of Day market cap according to different sources

On Apr 16th, 2025 the market cap of Celltrion was reported to be:

ยฃ18.53 Billion
by Yahoo Finance info icon info icon
ยฃ18.53 Billion
by CompaniesMarketCap info icon info icon